Perioperative tranexamic acid use is a popular choice among many surgeons for reducing surgical blood loss and its sequelae. While there is evidence in the literature that tranexamic acid use is effective in reducing blood loss in surgery for patients with hip fractures, there is less information on whether it leads to thromboembolic complications. We undertook a retrospective study in patients with hip fractures at two local hospitals to investigate if there was an increased risk of venous thromboembolism in patients who received tranexamic acid, and whether it reduced perioperative blood loss and the need for transfusion. We found that tranexamic acid used in patients undergoing hip fracture surgery reduced the drop in postoperative haemoglobin and the need for postoperative blood transfusion but was not associated with an increased risk of venous thromboembolism.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1750458920905772DOI Listing

Publication Analysis

Top Keywords

tranexamic acid
20
risk venous
12
venous thromboembolism
12
blood loss
12
perioperative tranexamic
8
hip fracture
8
patients hip
8
hip fractures
8
increased risk
8
acid
5

Similar Publications

Navigating coagulopathy in obstetric hemorrhage: The role of point-of-care testing.

Best Pract Res Clin Anaesthesiol

September 2024

Department of Anaesthesia and Perioperative Medicine, Cardiff and Vale University Hospital, Cardiff, UK.

Postpartum hemorrhage (PPH) remains the leading cause of maternal mortality and morbidity worldwide. Recent advances in understanding the hemostatic changes of pregnancy and PPH have led to the development of obstetric-specific approaches to resuscitation. This article aims to examine.

View Article and Find Full Text PDF

Postpartum hemorrhage assessment and targeted treatment.

Best Pract Res Clin Anaesthesiol

September 2024

Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA. Electronic address:

Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide, and mitigating it is a global health priority. In this review, we discuss the measurement, assessment, and treatment of PPH. We review different methods of quantifying blood loss, including gravimetry, calibrated drapes and canisters, and colorimetric techniques.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the use and safety of intravenous tranexamic acid (TXA) in patients undergoing surgery for intracranial meningiomas, focusing on how different doses affected outcomes.
  • A total of six randomized controlled trials with 881 patients were analyzed, revealing that TXA significantly reduced intraoperative blood loss, blood transfusion rates, surgery duration, and hospital stay lengths, but did not increase postoperative complications.
  • The findings suggested that a preoperative dose of 20 mg/kg with an intraoperative maintenance dose was effective in minimizing blood loss, although further research is needed to confirm these observations and optimize dosing strategies.
View Article and Find Full Text PDF
Article Synopsis
  • This study developed a method for intracellular calcium imaging in adult rat spinal cord slices to understand neuronal activity better.
  • The research found that the type of stimulation used (A-fiber vs. C-fiber) affected the calcium responses, with different intensity levels leading to distinct response patterns.
  • Results showed that certain drugs, like morphine, significantly suppressed calcium responses, while others, like bicuculline and high doses of tranexamic acid, enhanced them, allowing for insights into pain transmission and modulation in the spinal cord.
View Article and Find Full Text PDF

Background: Hemoptysis, the expectoration of blood from the lower respiratory tract, varies in severity and necessitates effective management to mitigate morbidity. Traditional treatments include bronchial artery embolization and pharmacological approaches. Tranexamic acid (TXA), an antifibrinolytic agent known for its efficacy in reducing bleeding during surgery and trauma, is being explored for its efficacy in treating Hemoptysis via both intravenous and inhalational routes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!